Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature

Table 2

Outcomes of oligometastases and oligo-recurrence in the liver.

Author	Year	Study design	Treatment method	Local control (%)	Overall survival (%)
Choti et al. [39]	2002	retrospective	surgery	—	40 (5 years)
Pawlik et al. [40]	2005	retrospective	surgery	—	58 (5 years)
Adam et al. [41]	2009	retrospective	chemotherapy → surgery	—	33 (5 years)
Bismuth et al. [42]	1996	retrospective	chemotherapy → surgery	—	40 (5 years)
van der Pool et al. [43]	2010	retrospective	SBRT	74 (2 years)	83 (5 years)
Romero et al. [44]	2006	prospective	SBRT	86 (2 years)	62 (5 years)
Rusthoven et al. [45]	2009	prospective	SBRT	92 (2 years)	30 (5 years)

Abbreviations: SBRT: stereotactic body radiation therapy.